Order of the Supreme Court of India in the matter of Network of People Living With HIV/AIDS & Others Vs Union of India & Others dated 24/02/2025. The Supreme Court (SC), February 24, 2025 has directed all states to file their affidavits addressing concerns raised about antiretroviral therapy (ART) drugs …
The wait for a faster and a more economical testing method for suspected tuberculosis cases may finally be over. The state health department will soon launch a new testing device, called Gene X-pert, which can generate a TB-test report within two hours. To be launched as part of a pilot …
DoP to continue with production cost-based model for pricing of essential drugs The department of pharmaceuticals has decided to abandon its controversial “industry-friendly” proposal to cap retail prices of essential medicines at the average price of the three best-selling brands and stick with the cost of production as the parameter. …
The alleged illegal clinical trials of untested drugs by pharmaceutical firms in the country, has come under the judicial scrutiny with the Supreme Court seeking the Centre's stand on a plea for an independent probe into it. A bench of justices R.M. Lodha and H.L. Gokhale issued notices to the …
The Railway Budget has yet again failed to provide any budgetary provision for new rail lines despite a feasibility survey having been completed by the Railways. Though some new rail lines have now been placed for evaluation before the Planning Commission, there was nothing encouraging for the state’s industry. The …
Move may weigh on other similar tie-ups with Indian cos, Biocon shares plunge 6.3% to . 250.8 on BSE. Pfizer Inc has terminated a deal to sell Biocon’s insulin products globally, dealing the Indian company a blow and calling into question similar tieups because of a change in the US …
The government today asserted India would invoke the flexibility it had under the WTO agreement on Trade Related Intellectual Property Rights (TRIPs) for compulsory licensing of patented drugs to ensure availability of life saving drugs at affordable prices to its people. The Controller General of Patents, Designs and Trademarks had …
Cancer-treatment drug Nexavar will soon be available at Rs. 8,880 per pack of 120 tablets. Bayer, a German multi-national, holds the patent for Nexavar (the brand name of sorafenib tosylate), which now sells at Rs.2.84 lakh. The way for such a huge reduction in the price is cleared with India …
India’s first compulsory licence worries MNC drugmakers The government has allowed a local drugmaker to make and sell a patented cancer drug at a fraction of the price charged by Germany’s Bayer AG, setting a precedent for more such efforts by Indian firms and heightening the global pharmaceutical industry’s anxiety …
A non-government organisation campaigning for cheaper essential drugs has proposed an alternative pricing model that seeks to fix retail prices at the average price of all brands in a segment. The proposal of the All India Drug Action Network (AIDAN) is being examined by the department of pharmaceuticals (DoP), an …
Mumbai: In a landmark decision that could set a precedent on how life-saving drugs under patents can be made affordable, the government has allowed a domestic company, Natco Pharma, to manufacture a copycat version of Bayer’s patented anti-cancer drug, Nexavar, bringing down its price by 97 %.. In the first-ever …
Doctors are waking up to the dangers of taking vitamin supplements in excess What Overdosing On These Can Do • Vitamin A Eczema, respiratory tract infection, blurred vision, ringing in the ears, insomnia, nausea, vomiting, diarrhoea, hair loss, joint pain, menstrual irregularities, liver damage. • Vitamin D Calcium deposition, deafness, …
JAIPUR: Information and public relations minister Jitendra Singh on Sunday said the state government will make all efforts to make cancer treatment 100% free in the state which include various therapies related to cancer treatment. He was speaking at a free camp to cousel cancer patients organised by the Rajasthan …
Drug-resistant Plasmodium falciparum parasite poses a great problem for the malaria control programme of any country. The most commonly used antimalarial drugs, viz. chloroquine (CQ) and sulphadoxine-pyrimethamine (SP) have been rendered ineffective and are replaced by the artesunate-based combination therapy (ACT).
Karimganj (Assam): A team of doctors on Monday confirmed that most workers of a tea estate, where death due to malnutrition have been alleged by a rights body, were suffering from it. The team, consisting of doctors from Civil Hospital, Cachar Cancer Hospital and Kalyani Hospital, examined about 500 patients …
India has strongly opposed an anticounterfeiting trade agreement by a small group of countries including the US, Switzerland, Canada and Japan recently, which it feels will be used to stop the country's generic drug exports. Nw Delhi has said the agreement is at the behest of the multinational companies that …
Mumbai: There may soon be changes in the labelling of widely-used cholesterol lowering drugs — statins — sold in the country. The US Food and Drug Administration (FDA) warned that patients taking statins may face a “small increased risk” of higher blood-sugar levels and diabetes. Doctors here said that these …
In recent years, there has been much work done due to increasing recognition that children need better medicines. The United States of America and the European Union have adopted regulations to encourage research and development of medicines for children; the World Health Organization (WHO) has been promoting “Make medicines child …
According to this WHO annual report on tuberculosis, India has recorded about 63,000 cases of notified multi-drug resistant tuberculosis (MDR-TB) in 2010, the highest in the South East Asia region. Countries in the WHO South-East Asia (SEA) Region have made significant progress towards the TB-related Millennium Development Goals (MDGs). The …
- Institute to foray into production from March to make medicines available at affordable prices The CSIR-North East Institute of Science and Technology, which has so far concentrated on research, has decided to foray into production from March with the manufacture of two herbal medicines. Director P.G. Rao said the …
